DOTA Conjugated JM#21 derivative 7 [CAS 3033865-40-3]
DOTA Conjugated JM#21 derivative 7 [CAS 3033865-40-3]
SKU:QM-0094878
Request quote or documents
![DOTA Conjugated JM#21 derivative 7 [CAS 3033865-40-3]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
DOTA Conjugated JM#21 derivative 7 (compound Ligand-7) is a derivative of CXCR4 targeting peptide conjugated with DOTA and can be used to produce radioligands. Radiolabeled DOTA Conjugated JM#21 derivative 7, i.e., 177Lu-DOTA, has excellent CXCR4 tumor targeting. In vitro biodistribution results of 177Lu-DOTA showed very low uptake in all non-targeted organs except kidney[1]. DOTA Conjugated JM#21 derivative 7 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .
-
CAS Number
[3033865-40-3]
-
Molecular Formula
C66H114N22O16
-
Molecular Weight
1471.75
-
Smiles
O=C([C@H](N)[C@@H](CC)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCCNC(CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)=O)=O)CCCCN)=O)CCCNC(N)=N)=O)CO)=O)CC2=CNC3=CC=CC=C23)=O)CCCNC(N)=N)=O)CC(C)C
-
Target
CXCR; Radionuclide-Drug Conjugates (RDCs)
-
Isoform
RDC Peptide
-
Shipping Conditions
Room temperature
Related Products
- QM-0054913 β-D-Galactopyranose,2,3,4,6-tetrakis-O- (phenylmethyl),1-acetate [CAS 3866-62-4]
- QM-0054549-01 β-Cyclogeranyltriphenylphosphonium bromide-d5 [CAS 78995-97-8]
- QM-0053803 γ-Linolenic acid ethyl ester-d5
- QM-0052832 β-D-Galactopyranoside,2-phenyl-1,3-dioxan-5-yl,2,3,4,6-tetraacetate [CAS 213264-93-8]
- QM-0052686-01 β-Phenyl GHB (sodium) [CAS 40951-19-7]
- QM-0052524 β-Nicotinamide mononucleotide, reduced form (disodium) (Standard) [CAS 108347-85-9]
- QM-0052354-01 ω-azido-C6 Ceramide [CAS 2108102-18-5]
- QM-0051897-01 β-D-Galactopyranoside,2-nitrophenyl,2,3,4,6-tetraacetate [CAS 3053-17-6]
- QM-0051893 β-D-Glucopyranoside,2-chloro-4-nitrophenyl,2,3,4,6-tetraacetate [CAS 35023-71-3]
- QM-0051820-01 β-D-Glucopyranuronic acid, methyl ester,1,2,3,4-tetrakis (2-methylpropanoate) [CAS 150607-94-6]
Other industry favorites
- QM-0054913 β-D-Galactopyranose,2,3,4,6-tetrakis-O- (phenylmethyl),1-acetate [CAS 3866-62-4]
- QM-0054549-01 β-Cyclogeranyltriphenylphosphonium bromide-d5 [CAS 78995-97-8]
- QM-0002296-01 β-Funaltrexamine (hydrochloride) [CAS 72786-10-8]
- QM-0206006 β-Nicotinamide adenine dinucleotide reduced (dipotassium) [CAS 104809-32-7]
- QM-0070478 β-D-Ribofuranose analogue 1 [CAS 89129-10-2]
- QM-0105480 α-Methyl-DL-phenylalanine [CAS 1132-26-9]
- QM-0017823 α-[2- (Methylamino) ethyl]benzenemethanol (Standard) [CAS 42142-52-9]
- QM-0016946-01 β-Carboline-1-carboxylic acid [CAS 26052-96-0]
- QM-0126963-01 γ-Linolenic Acid methyl ester (Standard) [CAS 16326-32-2]
- QM-0124646-01 β-D-Glucopyranosiduronic acid, methyl, methyl ester,2,3,4-triacetate [CAS 34213-34-8]
DOTA Conjugated JM#21 derivative 7 [CAS 3033865-40-3]
DOTA Conjugated JM#21 derivative 7 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.